Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Letter to FDA Requesting Extension of Comment Period for Proposed Rule on Regulation of LDTs
-
ACMG Request to FDA to Extend Comment Period for Proposed Rule on Regulation of LDTs
-
Sign-on Letter Regarding the Novitas & FCSO Proposed LCD on Genetic Testing for Oncology
-
Sign-on Letter Concerning the Improving Care and Access to Nurses Act
-
Sign-on Letter Supporting the Reducing Hereditary Cancer Act
-
ACMG Response to USPSTF Proposed Research Plan for Lynch Syndrome
-
Sign-on Letter Opposing Updated VALID Act & ACM Exemption
-
Group Sign-on Letter Concerning the Improving Care and Access to Nurses (I CAN) Act
-
Sign-on Letter to Congressional Leadership Concerning the VALID Act
-
ACMG Comments on FDA Draft Guidance for Products Incorporating Genome Editing